U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07411001) titled 'Hypiend - Multicomponent Behavioral Intervention in Pre-puberal Children (Hypiend-PPC)' on Dec. 12, 2025.
Brief Summary: This study is part of the European Hypiend project, which aims to explore the effects of co-exposure to endocrine disruptor chemicals (EDCs) on the function and epigenetic programming of the hypothalamic-pituitary-adrenal (HPA) axis in order to define intervention strategies to minimize exposure and consequences on the neuroendocrine system during the perinatal and prepubertal phases. The intervention at the perinatal phase is registered under the Unique Protocol ID: 101137440 - Hypiend - Clinical study to evaluat...